Dr. Saima Jabeen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 608 City Route 66, St. Robert, MO 65584 Phone: 573-336-5100 Fax: 573-336-3118 |
News Archive
The state Assembly approved a bill Thursday that would give state regulators the power to reject or modify excessive health insurance premium increases similar to the way auto and homeowner insurance is regulated in California. Lawmakers voted 47-28 to approve the measure after Republican legislators walked off the floor in protest. AB52 now moves to the state Senate.
Researchers in India have conducted a meta-analysis investigating the effects of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes among patients with COVID-19.
The invasive and expensive diagnosis process of bladder cancer, which is one of the most common and aggressive cancers in the United States, may be soon helped by a novel non-invasive diagnostic method thanks to advances in machine learning research at the San Diego Supercomputer Center, Moores Cancer Center, and CureMatch Incorporated.
By voice vote, the task force called on the National Association of Insurance Commissioners to endorse legislation by Rep. Mike Rogers that would exclude fees paid to agents and brokers when calculating how much health plans are spending on administrative costs versus medical care.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
› Verified 6 days ago